Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 1—January 2014
Research

Population-based Surveillance for Bacterial Meningitis in China, September 2006–December 2009

Yixing Li1, Zundong Yin1, Zhujun Shao1, Manshi Li, Xiaofeng Liang, Hardeep S. Sandhu, Stephen C. Hadler, Junhong Li, Yinqi Sun, Jing Li, Wenjing Zou, Mei Lin, Shuyan Zuo, Leonard W. Mayer, Ryan T. Novak, Bingqing Zhu, Li Xu, Huiming LuoComments to Author , and the Acute Meningitis and Encephalitis Syndrome Study Group
Author affiliations: Chinese Center for Disease Control and Prevention, Beijing, China (Y. Li, Z. Yin, X. Liang, J. Li, H. Luo ); National Institute for Communicable Disease Control and Prevention, Beijing (Z. Shao); Shandong Provincial Center for Disease Control and Prevention, Jinan, China (M. Li); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (H.S. Sandhu, S.C. Hadler, L.W. Mayer, R.T. Novak); Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, China (Y. Sun, J. Li); Hubei Provincial Center for Disease Control and Prevention, Wuhan, China (W. Zou); Guangxi Zhuang Autonomous Regional Center for Disease Control and Prevention, Nanning, China (M. Lin); World Health Organization China Office, Beijing (S. Zuo); State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China (B. Zhu, L. Xu )

Main Article

Table 3

Demographic information for AMES case-patients meeting the World Health Organization definition for probable bacterial meningitis, China, September 2006–December 2009*

Demographic variable % PMB case-patients (no. with CSF specimen/no. total), by province/prefecture
% total PBM case-patients (no. with CSF specimen/no. total), n = 3,464
Shandong/Jinan, n = 1,007 Hubei/Yichang, n = 751 Hebei/Shijiazhuang, n = 575 Guangxi/Guigang, n = 1,131
Total PBM patients
28.6 (288/1,007)
15.8 (119/751)
31.0 (178/575)
21.9 (248/1,131)
24.0 (833/3,464)
Case-patient age, y
<2 28.9 (39/135) 26.8 (11/41) 47.0 (95/202) 22.0 (54/246) 31.9 (199/624)
2–4 29.5 (62/210) 16.7 (8/48) 25.0 (23/92) 24.7 (47/190) 25.9 (140/540)
5–14 30.6 (102/333) 16.1 (25/155) 20.9 (37/177) 20.8 (57/274) 23.5 (221/939)
15–29 23.3 (31/133) 14.1 (22/156) 28.1 (16/57) 20.4 (21/103) 20.0 (90/449)
30–44 28.4 (29/102) 17.1 (28/164) 19.0 (4/21) 24.7 (21/85) 22.0 (82/372)
>45
26.6 (25/94)
13.4 (25/187)
11.5 (3/26)
20.6 (48/233)
18.7 (101/540)
Case-patient sex
M 30.3 (191/630) 17.1 (79/463) 30.7 (107/349) 20.9 (147/705) 24.4 (524/2,147)
F
25.7 (97/377)
13.9 (40/288)
31.4 (71/226)
23.7 (101/426)
23.5 (309/1,317)
Case-patient place of residence
Residents 31.9 (166/521) 15.4 (106/687) 25.7 (45/175) 21.6 (241/1,116) 22.3 (558/2,499)
Non-residents
25.1 (122/486)
20.3 (13/64)
33.3 (133/400)
46.7 (7/15)
28.5 (275/965)
Yearly PBM incidence/100,000 population
All residents
Crude rate 0.82 0.81 0.33 2.20
Adjusted rate* 2.61 1.84 2.26 2.93
Residents <5 y old
Crude rate 4.16 2.16 3.22 14.21
Adjusted rate† 8.41 6.95 14.47 22.30

*AMES, acute meningitis and encephalitis syndrome; PBM, probable bacterial meningitis.
†Adjusted rate was calculated based on PBM positivity among resident case-patients by age and initial clinical diagnosis applied to all cases without cerebrospinal fluid specimen and profile. Two assumptions were made when adjusting the rate: (1) the subset tested is a representative specimen of AMES cases, and (2) there was a homogenous rate of infection within a given prefecture, age group, and initial clinical diagnosis stratum.

Main Article

1These authors contributed equally to this article.

2Members of the Acute Meningitis and Encephalitis Syndrome Study Group are listed at the end of this article.

Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external